These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

242 related items for PubMed ID: 30358104

  • 1. Circulating pancreatic cancer exosomal RNAs for detection of pancreatic cancer.
    Kitagawa T, Taniuchi K, Tsuboi M, Sakaguchi M, Kohsaki T, Okabayashi T, Saibara T.
    Mol Oncol; 2019 Feb; 13(2):212-227. PubMed ID: 30358104
    [Abstract] [Full Text] [Related]

  • 2. Plasma-derived exosomal long noncoding RNAs of pancreatic cancer patients as novel blood-based biomarkers of disease.
    He X, Chen L, Di Y, Li W, Zhang X, Bai Z, Wang Z, Liu S, Corpe C, Wang J.
    BMC Cancer; 2024 Aug 06; 24(1):961. PubMed ID: 39107726
    [Abstract] [Full Text] [Related]

  • 3. Validation of four candidate pancreatic cancer serological biomarkers that improve the performance of CA19.9.
    Makawita S, Dimitromanolakis A, Soosaipillai A, Soleas I, Chan A, Gallinger S, Haun RS, Blasutig IM, Diamandis EP.
    BMC Cancer; 2013 Sep 03; 13():404. PubMed ID: 24007603
    [Abstract] [Full Text] [Related]

  • 4. Trefoil factor(s) and CA19.9: A promising panel for early detection of pancreatic cancer.
    Jahan R, Ganguly K, Smith LM, Atri P, Carmicheal J, Sheinin Y, Rachagani S, Natarajan G, Brand RE, Macha MA, Grandgenett PM, Kaur S, Batra SK.
    EBioMedicine; 2019 Apr 03; 42():375-385. PubMed ID: 30956167
    [Abstract] [Full Text] [Related]

  • 5. Combined serum CA19-9 and miR-27a-3p in peripheral blood mononuclear cells to diagnose pancreatic cancer.
    Wang WS, Liu LX, Li GP, Chen Y, Li CY, Jin DY, Wang XL.
    Cancer Prev Res (Phila); 2013 Apr 03; 6(4):331-8. PubMed ID: 23430754
    [Abstract] [Full Text] [Related]

  • 6. Serum dickkopf-1 is a novel serological biomarker for the diagnosis and prognosis of pancreatic cancer.
    Han SX, Zhou X, Sui X, He CC, Cai MJ, Ma JL, Zhang YY, Zhou CY, Ma CX, Varela-Ramirez A, Zhu Q.
    Oncotarget; 2015 Aug 14; 6(23):19907-17. PubMed ID: 26101916
    [Abstract] [Full Text] [Related]

  • 7. An elevated expression of serum exosomal microRNA-191, - 21, -451a of pancreatic neoplasm is considered to be efficient diagnostic marker.
    Goto T, Fujiya M, Konishi H, Sasajima J, Fujibayashi S, Hayashi A, Utsumi T, Sato H, Iwama T, Ijiri M, Sakatani A, Tanaka K, Nomura Y, Ueno N, Kashima S, Moriichi K, Mizukami Y, Kohgo Y, Okumura T.
    BMC Cancer; 2018 Jan 31; 18(1):116. PubMed ID: 29385987
    [Abstract] [Full Text] [Related]

  • 8. MicroRNA biomarkers in whole blood for detection of pancreatic cancer.
    Schultz NA, Dehlendorff C, Jensen BV, Bjerregaard JK, Nielsen KR, Bojesen SE, Calatayud D, Nielsen SE, Yilmaz M, Holländer NH, Andersen KK, Johansen JS.
    JAMA; 2018 Jan 31; 311(4):392-404. PubMed ID: 24449318
    [Abstract] [Full Text] [Related]

  • 9. CEACAM1, a novel serum biomarker for pancreatic cancer.
    Simeone DM, Ji B, Banerjee M, Arumugam T, Li D, Anderson MA, Bamberger AM, Greenson J, Brand RE, Ramachandran V, Logsdon CD.
    Pancreas; 2007 May 31; 34(4):436-43. PubMed ID: 17446843
    [Abstract] [Full Text] [Related]

  • 10. Serum tumor antigen REG4 as a diagnostic biomarker in pancreatic ductal adenocarcinoma.
    Takayama R, Nakagawa H, Sawaki A, Mizuno N, Kawai H, Tajika M, Yatabe Y, Matsuo K, Uehara R, Ono K, Nakamura Y, Yamao K.
    J Gastroenterol; 2010 May 31; 45(1):52-9. PubMed ID: 19789838
    [Abstract] [Full Text] [Related]

  • 11. Exosomal long noncoding RNA lnc-GNAQ-6:1 may serve as a diagnostic marker for gastric cancer.
    Li S, Zhang M, Zhang H, Hu K, Cai C, Wang J, Shi L, Ma P, Xu Y, Zheng P.
    Clin Chim Acta; 2020 Feb 31; 501():252-257. PubMed ID: 31730812
    [Abstract] [Full Text] [Related]

  • 12. Identification of Circulating MiR-25 as a Potential Biomarker for Pancreatic Cancer Diagnosis.
    Deng T, Yuan Y, Zhang C, Zhang C, Yao W, Wang C, Liu R, Ba Y.
    Cell Physiol Biochem; 2016 Feb 31; 39(5):1716-1722. PubMed ID: 27639768
    [Abstract] [Full Text] [Related]

  • 13. Combined Exosomal GPC1, CD82, and Serum CA19-9 as Multiplex Targets: A Specific, Sensitive, and Reproducible Detection Panel for the Diagnosis of Pancreatic Cancer.
    Xiao D, Dong Z, Zhen L, Xia G, Huang X, Wang T, Guo H, Yang B, Xu C, Wu W, Zhao X, Xu H.
    Mol Cancer Res; 2020 Feb 31; 18(2):300-310. PubMed ID: 31662449
    [Abstract] [Full Text] [Related]

  • 14. Pancreatic cancer serum biomarker PC-594: Diagnostic performance and comparison to CA19-9.
    Ritchie SA, Chitou B, Zheng Q, Jayasinghe D, Jin W, Mochizuki A, Goodenowe DB.
    World J Gastroenterol; 2015 Jun 07; 21(21):6604-12. PubMed ID: 26074698
    [Abstract] [Full Text] [Related]

  • 15. Validation of N-glycan markers that improve the performance of CA19-9 in pancreatic cancer.
    Zhao YP, Zhou PT, Ji WP, Wang H, Fang M, Wang MM, Yin YP, Jin G, Gao CF.
    Clin Exp Med; 2017 Feb 07; 17(1):9-18. PubMed ID: 26714469
    [Abstract] [Full Text] [Related]

  • 16. New observations on the utility of CA19-9 as a biomarker in Lewis negative patients with pancreatic cancer.
    Luo G, Fan Z, Cheng H, Jin K, Guo M, Lu Y, Yang C, Fan K, Huang Q, Long J, Liu L, Xu J, Lu R, Ni Q, Warshaw AL, Liu C, Yu X.
    Pancreatology; 2018 Dec 07; 18(8):971-976. PubMed ID: 30131287
    [Abstract] [Full Text] [Related]

  • 17. Long non-coding RNA metastasis associated in lung adenocarcinoma transcript 1 derived miniRNA as a novel plasma-based biomarker for diagnosing prostate cancer.
    Ren S, Wang F, Shen J, Sun Y, Xu W, Lu J, Wei M, Xu C, Wu C, Zhang Z, Gao X, Liu Z, Hou J, Huang J, Sun Y.
    Eur J Cancer; 2013 Sep 07; 49(13):2949-59. PubMed ID: 23726266
    [Abstract] [Full Text] [Related]

  • 18. miR‑1246 and miR‑4644 in salivary exosome as potential biomarkers for pancreatobiliary tract cancer.
    Machida T, Tomofuji T, Maruyama T, Yoneda T, Ekuni D, Azuma T, Miyai H, Mizuno H, Kato H, Tsutsumi K, Uchida D, Takaki A, Okada H, Morita M.
    Oncol Rep; 2016 Oct 07; 36(4):2375-81. PubMed ID: 27573701
    [Abstract] [Full Text] [Related]

  • 19. The Combination of Neutrophil-to-lymphocyte Ratio and Serum Carbohydrate Antigen 19-9 Level as a Prognostic Indicator in Patients with Recurrent Pancreatic Cancer.
    Sakamoto T, Saito H, Uchinaka EI, Morimoto M, Amisaki M, Tokuyasu N, Honjo S, Ashida K, Fujiwara Y.
    Anticancer Res; 2018 Sep 07; 38(9):5497-5503. PubMed ID: 30194208
    [Abstract] [Full Text] [Related]

  • 20. Verification of the effectiveness of fucosylated haptoglobin as a pancreatic cancer marker in clinical diagnosis.
    Kuwatani M, Kawakami H, Kubota Y, Kawakubo K, Ito YM, Togo S, Ikeda T, Kusama K, Kobayashi Y, Murata T, Sakamoto N.
    Pancreatology; 2019 Jun 07; 19(4):569-577. PubMed ID: 31031206
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.